April 3, 2018


Discover Magazine’s Neuroskeptic blog reviewed Mark’s recent papers on the dissociative side effects of ketamine and a recent publication on a treatment-resistant depression trial that was halted with the repurposed antihypertensive and anti-insulin medication diazoxide.

October 3, 2018


We welcome Sage Comstock to the lab as a our first hire! She will be working on the clinical research end, especially the Ketamine Alcohol study as it transitions from the NIH/NIMH to UIHC.

December 24, 2018


Happy Holidays! We welcome two recent new hires to the lab, Amanda Decker and Jacob (Jake) Dale. Amanda started in late November and will be using human induced pluripotent stem cell-derived three-dimensional organoid cultures to study drug response including ketamine, alcohol and opioids. Jake joined the lab in early December and will be our laboratory manager organizing and assisting with all aspects of cell culture and subsequent experimentation.